Back
Galmed Pharmaceuticals Vs. Can Fite Biofarma Industry Stock Comparison
Sell
7
GLMD
Galmed Pharmaceuticals
Last Price:
2.90
Seasonality Move:
13.88%
Sell
42
CANF
Can Fite Biofarma
Last Price:
1.95
Seasonality Move:
-4.74%
Sell
7
Galmed Pharmaceuticals (GLMD)
is a Sell
Is Galmed Pharmaceuticals a Buy, Sell or Hold?
- The current Galmed Pharmaceuticals [GLMD] share price is $2.93. The Score for GLMD is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
- GLMD is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
42
Can Fite Biofarma (CANF)
is a Sell
Is Can Fite Biofarma a Buy, Sell or Hold?
- The current Can Fite Biofarma [CANF] share price is $1.96. The Score for CANF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- CANF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GLMD Stock Price Chart
What is Galmed Pharmaceuticals's stock price today?
-
The Galmed Pharmaceuticals share price today is $2.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLMD is experiencing selling pressure, which indicates risk of future bearish movement.
CANF Stock Price Chart
What is Can Fite Biofarma's stock price today?
-
The Can Fite Biofarma share price today is $1.96
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing selling pressure, which indicates risk of future bearish movement.
GLMD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.43 | Sell |
| Relative Strength Index (14 RSI): | 39.04 | Sell |
| Chaikin Money Flow: | -19608 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.01 - 4.09) | Sell |
| Bollinger Bands (100): | (2.42 - 5.86) | Sell |
CANF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 33.81 | Sell |
| Chaikin Money Flow: | -36669 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.07 - 2.65) | Sell |
| Bollinger Bands (100): | (2.02 - 3.08) | Sell |
GLMD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3 | Sell |
| 20-day SMA: | 3.51 | Sell |
| 50-day SMA: | 4.72 | Sell |
| 200-day SMA: | 4.26 | Sell |
| 8-day EMA: | 3.07 | Sell |
| 20-day EMA: | 3.43 | Sell |
| 50-day EMA: | 3.99 | Sell |
| 200-day EMA: | 7.08 | Sell |
CANF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.07 | Sell |
| 20-day SMA: | 2.28 | Sell |
| 50-day SMA: | 2.25 | Sell |
| 200-day SMA: | 2.4 | Sell |
| 8-day EMA: | 2.07 | Sell |
| 20-day EMA: | 2.19 | Sell |
| 50-day EMA: | 2.29 | Sell |
| 200-day EMA: | 2.48 | Sell |
Galmed Pharmaceuticals Earnings Growth & GLMD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.70 per share, and an increase next year of $0.02 per share.
Can Fite Biofarma Earnings Growth & CANF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and an increase next year of $0.04 per share.
Galmed Pharmaceuticals Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Can Fite Biofarma Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||